PT-112
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for PT-112, covering 2018-04-25 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: PT-112 in Subjects With Thymoma and Thymic Carcinoma [Phase 2]